Franklin Resources
NVLN

Franklin Resources’s Novelion Therapeutics Inc. Common Shares NVLN Stock Holding History

Franklin Resources’s Portfolio NVLN Stock Details NVLN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-15,055
Closed -$45K – 1558
2018
Q3 		$45K Sell
15,055
-2,706
-15% -$9.58K ﹤0.01% 1510
2018
Q2 		$65K Sell
17,761
-690
-4% -$2.77K ﹤0.01% 1459
2018
Q1 		$65K Buy
18,451
+2,370
+15% +$10K ﹤0.01% 1495
2017
Q4 		$50K Buy
16,081
+1,254
+8% +$6.03K ﹤0.01% 1499
2017
Q3 		$104K Buy
14,827
+2,029
+16% +$16.3K ﹤0.01% 1469
2017
Q2 		$118K Buy
12,798
+511
+4% +$4.92K ﹤0.01% 1484
2017
Q1 		$132K Buy
+12,287
New +$126K ﹤0.01% 1475

Other funds holding NVLN

EIG
EdgePoint Investment Group Toronto, Ontario, Canada $12.5B AUM 31.7% 1-Year Est. Return
HVC
Healthcare Value Capital Woodcliff Lake, New Jersey $38.5M AUM 24.72% 1-Year Est. Return
BC
Broadfin Capital New York $403M AUM 100.56% 1-Year Est. Return
HCM
Highbridge Capital Management New York $1.58B AUM 31.19% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $114M AUM 77.6% 1-Year Est. Return
JAM
JW Asset Management Miami Beach, Florida $244M AUM 71.51% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
Millennium Management
Millennium Management New York $134B AUM 35.51% 1-Year Est. Return
DMK
David M. Knott $264M AUM 59.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return